Entera Bio Ltd. WT EXP 06...

NASDAQ: ENTXW · Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jun 27, 2023, 8:42 PM

Entera Bio WT EXP 062723 Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-9.54M -8.89M -13.07M -12.19M
Depreciation & Amortization
46K 56K 64K 53K
Stock-Based Compensation
2.56M 1.69M 2.25M 1.86M
Other Working Capital
189K -507K -1.62M 1.33M
Other Non-Cash Items
-5K n/a -78K 18K
Deferred Income Tax
14K 29K 174K -217K
Change in Working Capital
112K -195K -1.83M 1.41M
Operating Cash Flow
-6.82M -7.31M -12.5M -9.06M
Capital Expenditures
-3K -17K -47K -17K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -55K n/a
Investing Cash Flow
-3K -17K -102K -17K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
516K -580K 13K 3.58M
Financial Cash Flow
4.48M 6.04M 13K 25.38M
Net Cash Flow
-2.35M -1.29M -12.59M 16.3M
Free Cash Flow
-6.82M -7.33M -12.55M -9.08M